This is a podcast that will help you navigate the complexities of dementia. It’s presented by two friends who come at the subject from two very different perspectives.
Professor Julie Williams has spent most of her working life trying to understand Alzheimer's disease and other forms of dementia. Meanwhile, Justine Pickering understands the colossal human cost all too well. She lost her mum to a rare form of young-onset dementia before founding a unique respite project for families coping with the emotional toll of the disease.
In Two Minds brings you the highs and lows of the shared experiences of dementia. We’ll hear inspiring special guests and all about current research and future treatments.
Together, we’ll explore the challenges of coping with this disease and how to live well following diagnosis.
All content for In Two Minds is the property of Justine Pickering and Professor Julie Williams and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This is a podcast that will help you navigate the complexities of dementia. It’s presented by two friends who come at the subject from two very different perspectives.
Professor Julie Williams has spent most of her working life trying to understand Alzheimer's disease and other forms of dementia. Meanwhile, Justine Pickering understands the colossal human cost all too well. She lost her mum to a rare form of young-onset dementia before founding a unique respite project for families coping with the emotional toll of the disease.
In Two Minds brings you the highs and lows of the shared experiences of dementia. We’ll hear inspiring special guests and all about current research and future treatments.
Together, we’ll explore the challenges of coping with this disease and how to live well following diagnosis.
From Big Data to Big Breakthroughs: Caleb Webber on Parkinson’s
In Two Minds
32 minutes
2 weeks ago
From Big Data to Big Breakthroughs: Caleb Webber on Parkinson’s
In this powerful and hopeful episode of In Two Minds, Professor Caleb Webber explains how vast new datasets and AI-driven pattern-spotting are transforming our understanding of conditions like Parkinson’s and Alzheimer’s.
Caleb is the Director of Informatics at the UK Dementia Research Institute and a leading voice in decoding the complexities of neurodegenerative disease. He reveals groundbreaking findings from his team’s work: surprising overlaps between Parkinson’s and diabetes, the discovery that existing hypertension medications may halve the risk of developing Parkinson’s, and a major new study exploring whether combining blood-pressure drugs with GLP-1 therapies (like Ozempic-type medications) could slow or even prevent the disease.
Caleb offers real reasons for optimism: that prevention may be within reach, that repurposed medications could help people sooner than expected, and that the next decade of brain-health research looks more promising than any before.
This is an episode filled with science, humanity, and genuine hope — for people living with Parkinson’s today, for those caring for them, and for anyone navigating life touched by neurodegenerative disease.
We'd love to hear your stories and your advice for anyone living with dementia - or if you have any questions for Justine and Prof Julie. Email us hello@twomindspodcast.co.uk.
For further help and advice please visit https://www.alzheimers.org.uk
In Two Minds
This is a podcast that will help you navigate the complexities of dementia. It’s presented by two friends who come at the subject from two very different perspectives.
Professor Julie Williams has spent most of her working life trying to understand Alzheimer's disease and other forms of dementia. Meanwhile, Justine Pickering understands the colossal human cost all too well. She lost her mum to a rare form of young-onset dementia before founding a unique respite project for families coping with the emotional toll of the disease.
In Two Minds brings you the highs and lows of the shared experiences of dementia. We’ll hear inspiring special guests and all about current research and future treatments.
Together, we’ll explore the challenges of coping with this disease and how to live well following diagnosis.
